SEC Form 4 · accession 0001384101-18-000016
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Kennedy
Officer — Chief Financial Officer
Period of report
Mar 2, 2018
Accepted (ET)
Mar 5, 2018 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 2, 2018 | A | 10,300 | $0.00 | A | 28,114 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $5.98 | Mar 2, 2018 | A | 77,250 | A | — | Mar 2, 2028 | Common Stock | 77,250 | 77,250 | D |
Explanation of responses
- F1Restricted stock units (RSUs) awarded on March 2, 2018 vest 25% on March 2, 2019, and the remaining vest at a rate of 3/48 on each quarterly anniversary thereafter subject to continuing employment of the Reporting Person on each vesting date.
- F2Includes 2,209 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2018.
- F3The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous employment thereafter.